Medtronic announces MiniMed exchange results. What it means for Medtronic stock
Published on 10/17/2026 at 10:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSExchange results and next session
- Medtronic announced final MiniMed exchange results on October 14, 2026, accepting 55,032,401 ordinary shares.
- The exchange applied an 18.29 percent proration factor to most other valid tenders.
- The next Xetra session is scheduled for October 19, 2026.
Medtronic plc announced final results of its MiniMed Group, Inc. exchange offer on October 14, 2026. The company said it elected to exchange its remaining interest in MiniMed for 55,032,401 Medtronic ordinary shares.
MiniMed exchange results
The offer was oversubscribed. Medtronic reported that 297,521,390 ordinary shares were validly tendered and not withdrawn, while 296,763,500 shares were subject to proration. The final proration factor for those tenders was 18.289133 percent. Following the exchange offer, Medtronic said it would not retain any outstanding MiniMed shares. These details were provided in the company's release.
Market context: Market report S&P 500.
Next Xetra session
The next Xetra session is scheduled for October 19, 2026. The next price is shown from the start of trading by the continuously updated real-time quote of Medtronic plc stock.
